Selectis Health,Inc.
2.0000+0.05 (+2.56%)
Oct 29, 4:00:00 PM EDT · OTC Markets OTCQB · GBCS · USD
Key Stats
Market Cap
6.13MP/E (TTM)
-Basic EPS (TTM)
-1.04Dividend Yield
0%Recent Filings
10-Q
Q2 FY2025 results
Selectis Health posted Q2 revenue of $10.4M, up 9% y/y from $9.6M, driven by 11% higher healthcare revenue from Medicaid rate hikes in Georgia and Oklahoma facilities, while rental revenue vanished after last year's Archway sale. Operating loss narrowed to $450K from $764K y/y, thanks to lower G&A and depreciation, yet expenses climbed 5% on inflation-fueled operating costs. Net loss hit $308K, or $(0.10) per share on 3.07M diluted shares, versus a $794K profit last year boosted by a one-off asset gain; the gap stems from absent gains and steady interest. Cash stood at $560K with $772K restricted, supporting $958K operating cash flow for H1, but $32M debt looms with covenant breaches on two loans. A pending Georgia facility sale fell through in July. Ongoing litigation risks patient care claims.
8-K
Deal termination disrupts sale
Selectis Health's deal to sell its Georgia subsidiaries collapsed on July 13, 2025, when the buyer terminated the Purchase and Sale Agreement and Operations Transfer Agreement without closing. The agreements, announced February 7, 2025, now leave the company eyeing legal remedies. Deal busts sting. No financial impacts disclosed yet.
8-K
Stock upgrades to OTCQB
10-Q
Q1 FY2025 results
Selectis Health posted Q1 FY2025 revenue of $10.5M, up 10% y/y from $9.5M, driven by 12% higher healthcare revenue from Medicaid rate hikes in Georgia and Oklahoma facilities, while rental revenue vanished after last year's property sale. Operating loss narrowed to $422K from $696K y/y, thanks to lower depreciation and interest, yet expenses climbed 7% on inflation-fueled operating costs. Net loss improved to $656K or $(0.22) per diluted share on 3.1M shares, with the operating-to-net gap mainly from interest expense. Cash swelled to $1.3M, bolstered by $1.0M operating cash flow minus $219K capex for free cash flow of $816K (derived), against $32.4M debt at blended rates near 5-9%. A pending $27M sale of four Georgia skilled nursing facilities could reshape the portfolio. Ongoing litigation over patient care adds scrutiny.
10-K
FY2024 results
Selectis Health's FY2024 revenue climbed 7% year-over-year to $39.5M, propelled by a 13% surge in healthcare revenue to $39.2M from higher Medicaid rates in Georgia and Oklahoma facilities, while rental income halved to $0.3M after selling the Archway property mid-year. Operating losses narrowed to $2.7M from $9.0M, thanks to 3% lower property taxes and operating costs amid reduced headcount and fading COVID expenses, though Q4 momentum showed sequential margin compression from staffing pressures. Credit loss provisions dropped 62% to $1.0M as receivables aged better. A $2.1M gain from the Archway sale offset interest costs, yielding a net loss of $2.4M, or $(0.80) per share on 3.1M diluted shares. Debt stood at $32.1M net, with $13M due in 2025; lines of credit added $0.8M liquidity. No annual guidance issued. Yet occupancy risks from regulatory shifts loom large.
IPO
Website
Employees
Sector
Industry
BKD
Brookdale Senior Living Inc.
8.95+0.12
EHC
Encompass Health Corporation
125.63-0.65
HCA
HCA Healthcare, Inc.
468.40+1.94
LTC
LTC Properties, Inc.
34.63-0.56
LWSCF
Sienna Sr Living Inc.
13.58-0.48
NHC
National HealthCare Corporation
120.85-1.15
PACS
PACS Group, Inc.
12.44+0.02
RHEP
Regional Health Properties, Inc
1.25-0.04
SEM
Select Medical Holdings Corpora
14.28+0.06
SNDA
Sonida Senior Living, Inc.
25.73-0.44